Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-181,000
Closed -$1.32M 1463
2025
Q1
$1.32M Buy
181,000
+31,604
+21% +$276K 0.01% 714
2024
Q4
$1.17M Buy
149,396
+49,396
+49% +$407K 0.01% 827
2024
Q3
$740K Sell
100,000
-15,000
-13% -$126K 0.01% 869
2024
Q2
$921K Buy
115,000
+35,099
+44% +$313K 0.01% 776
2024
Q1
$930K Buy
79,901
+15,785
+25% +$175K 0.01% 847
2023
Q4
$716K Buy
64,116
+26,066
+69% +$240K ﹤0.01% 1094
2023
Q3
$587K Buy
+38,050
New +$639K 0.01% 1010
2023
Q2
Sell
-15,812
Closed -$241K 1777
2023
Q1
$241K Buy
+15,812
New +$206K ﹤0.01% 1299

Other funds holding ETNB

Jefferies Financial Group's ETNB Position: Q2 2025 in Review

Jefferies Financial Group sold out of 89bio (ETNB) in Q2 2025, closing a stake of 181,000 shares — an estimated $1.32M sold.

Jefferies Financial Group first reported a position in ETNB in Q1 2023 and held it in 8 quarters. The position peaked at $1.32M in Q1 2025. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • Jefferies Financial Group reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 181,000 89bio shares in Q2 2025, an estimated $1.32M.
  • Jefferies Financial Group first reported a position in 89bio in Q1 2023 and held it in 8 quarters.
  • Jefferies Financial Group's 89bio position peaked at $1.32M in Q1 2025.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on Jefferies Financial Group's 13F filing for Q2 2025, filed 12 Aug 2025.